These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32598856)

  • 1. Multiple Somatic Mutations for Clonal Hematopoiesis Are Associated With Increased Mortality in Patients With Chronic Heart Failure.
    Cremer S; Kirschbaum K; Berkowitsch A; John D; Kiefer K; Dorsheimer L; Wagner J; Rasper T; Abou-El-Ardat K; Assmus B; Serve H; Rieger M; Dimmeler S; Zeiher AM
    Circ Genom Precis Med; 2020 Aug; 13(4):e003003. PubMed ID: 32598856
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
    Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
    JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
    Abplanalp WT; Cremer S; John D; Hoffmann J; Schuhmacher B; Merten M; Rieger MA; Vasa-Nicotera M; Zeiher AM; Dimmeler S
    Circ Res; 2021 Jan; 128(2):216-228. PubMed ID: 33155517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
    Amorós-Pérez M; Fuster JJ
    Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
    Huang YC; Wang CY
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of clonal hematopoiesis in heart failure.
    Chavkin NW; Min KD; Walsh K
    Trends Cardiovasc Med; 2022 May; 32(4):198-203. PubMed ID: 33892102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Hematopoiesis Before, During, and After Human Spaceflight.
    Mencia-Trinchant N; MacKay MJ; Chin C; Afshinnekoo E; Foox J; Meydan C; Butler D; Mozsary C; Vernice NA; Darby C; Schatz MC; Bailey SM; Melnick AM; Guzman ML; Bolton K; Braunstein LZ; Garrett-Bakelman F; Levine RL; Hassane DC; Mason CE
    Cell Rep; 2020 Dec; 33(10):108458. PubMed ID: 33242405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis Is Associated With Long-Term Adverse Outcomes Following Cardiac Surgery.
    Ninni S; Vicario R; Coisne A; Woitrain E; Tazibet A; Stewart CM; Diaz LA; White JR; Koussa M; Dubrulle H; Juthier F; Jungling M; Vincentelli A; Edme JL; Nattel S; de Winther M; Geissmann F; Dombrowicz D; Staels B; Montaigne D
    J Am Heart Assoc; 2024 Sep; 13(17):e034255. PubMed ID: 39206728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
    Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ
    J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Clonal Hematopoiesis and Risk of Heart Failure.
    Bazeley P; Morales R; Tang WHW
    Curr Heart Fail Rep; 2020 Oct; 17(5):271-276. PubMed ID: 32772279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.
    Shumliakivska M; Luxán G; Hemmerling I; Scheller M; Li X; Müller-Tidow C; Schuhmacher B; Sun Z; Dendorfer A; Debes A; Glaser SF; Muhly-Reinholz M; Kirschbaum K; Hoffmann J; Nagel E; Puntmann VO; Cremer S; Leuschner F; Abplanalp WT; John D; Zeiher AM; Dimmeler S
    Nat Commun; 2024 Jan; 15(1):606. PubMed ID: 38242884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
    Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
    ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-intrinsic effects of clonal hematopoiesis in heart failure.
    Abplanalp WT; Schuhmacher B; Cremer S; Merten M; Shumliakivska M; Macinkovic I; Zeiher AM; John D; Dimmeler S
    Nat Cardiovasc Res; 2023 Sep; 2(9):819-834. PubMed ID: 39196061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity.
    Fuster JJ; Zuriaga MA; Zorita V; MacLauchlan S; Polackal MN; Viana-Huete V; Ferrer-Pérez A; Matesanz N; Herrero-Cervera A; Sano S; Cooper MA; González-Navarro H; Walsh K
    Cell Rep; 2020 Oct; 33(4):108326. PubMed ID: 33113366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.
    Dharan NJ; Yeh P; Bloch M; Yeung MM; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy JF; Woolley I; Pell C; Templeton DJ; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson SJ; Polizzotto MN; Dawson MA;
    Nat Med; 2021 Jun; 27(6):1006-1011. PubMed ID: 34099923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saliva-derived DNA is suitable for the detection of clonal haematopoiesis of indeterminate potential.
    O'Reilly RL; Burke J; Harraka P; Yeh P; Howlett K; Behrouzfar K; Rewse A; Tsimiklis H; Giles GG; Bubb KJ; Nicholls SJ; Milne RL; Southey MC
    Sci Rep; 2024 Aug; 14(1):18917. PubMed ID: 39143154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.